Atlas Trials

Homologous Recombination Deficiency in Chinese Ovarian Cancer Patients

Clinical trial NCT05044091 · UNKNOWN

Trial details

NCT number
NCT05044091
Sponsor
Xiaoxiang Chen
Status
UNKNOWN
Study type
OBSERVATIONAL
Ovarian CancerHRDPARP Inhibitor
Start date
2021-09-15
Primary completion
2022-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.